查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946985

2026年全球即时分子诊断市场报告

Point-Of-Care Molecular Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，照护现场分子诊断市场发展迅速，预计将从2025年的39.8亿美元成长到2026年的45.8亿美元，复合年增长率达15.0%。过去几年的成长归因于多种因素，例如感染疾病的日益普及、急诊诊断检测的扩展、对快速临床决策支援的需求不断增长、分子检测技术的进步以及医院对即时诊断技术的日益普及。

预计未来几年，照护现场分子诊断市场将快速成长，到2030年市场规模将达到79.1亿美元，复合年增长率（CAGR）为14.7%。预测期内的成长要素包括：居家分子检测的普及率不断提高、快速诊断基础设施投资增加、呼吸系统和肿瘤检测应用范围扩大、云端诊断平台的整合度不断提高，以及对疾病早期检测的日益重视。预测期内的主要趋势包括：快速分子检测平台的普及率不断提高、对分散式诊断解决方案的需求不断增长、自动化检体处理技术的整合度不断提高、综合征检测项目的扩展，以及对快速获得检测结果的日益重视。

感染疾病和呼吸系统疾病的急剧增加预计将对照护现场分子诊断市场的成长起到关键的推动作用。由病毒或细菌病原体引起的呼吸道感染疾病会影响呼吸系统，通常透过咳嗽、打喷嚏或直接接触传播。目前有多种治疗方法用于控制这些疾病，包括吸入器、口服药物、静脉注射疗法以及支持及时准确治疗的即时分子诊断解决照护现场。例如，根据英国卫生安全局的数据，2022年第40週至2023年第15週总合，英格兰108家国民医疗服务体系（NHS）信託机构共报告了1681例与确诊流感病例相关的加护病房（ICU）入院病例。与上一季相比，这数字大幅上升（2022年第39週，114家信託机构共通报182例住院病例，到2022年第39週上升至316例）。感染疾病和呼吸道疾病发病率的上升以及相关的死亡风险增加，正在推动对照护现场分子诊断解决方案的需求。

照护现场分子诊断市场的主要企业正致力于提供技术先进的解决方案，以增强其竞争优势。这些公司正在采用新一代即时分子诊断技术，包括酵素免疫分析法(ELISA)、聚合酵素链锁反应(PCR)、质谱 (MS)、原位杂合反应、频谱核型成像、DNA 微阵列及相关技术，以及相关服务，并将其整合到照护现场照护现场设备中，旨在缩短分析时间并降低整体成本。例如，2023 年 5 月，总部位于美国的诊断公司 Sensible Diagnostics 发布了照护现场PCR 系统。该公司利用了 Curative 在 COVID-19 疫情期间累积的诊断经验。 Sensible Diagnostics 迄今已进行了超过 200 万次 COVID-19就地检验，并表示其 PCR 平台可在 10 分钟内提供结果。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球即时分子诊断市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 快速分子检测平台的应用日益广泛
    • 对分散式诊断解决方案的需求日益增长
    • 自动化样品处理的整合度不断提高
    • 扩大综合征检测小组
    • 更加重视快速见效

第五章 终端用户产业市场分析

  • 医院
  • 分散式检查机构
  • 居家照护提供者
  • 老年人照护住宅
  • 诊断诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球即时分子诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球即时分子诊断市场规模、比较及成长率分析
  • 全球即时分子诊断市场表现：规模与成长，2020-2025年
  • 全球即时分子诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 检测方法和试剂盒、仪器和分析设备
  • 透过使用
  • 呼吸道感染疾病、胃肠道感染疾病、性行为感染感染（STI）、院内感染（HAI）、血流感染疾病及败血症相关感染疾病
  • 最终用户
  • 分散式检查机构、医院、居家医疗机构和辅助生活设施
  • 按类型细分：检测和试剂盒
  • 核酸增幅检查（NAAT）、快速诊断检测、分子检测试剂盒、试剂及耗材
  • 按类型细分：仪器和分析设备
  • 微流体装置、照护现场分析装置

第十章 区域与国家分析

  • 全球即时分子诊断市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球即时分子诊断市场：国家、绩效及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 即时分子诊断市场：竞争格局与市占率（2024 年）
  • 即时分子诊断市场：公司估值矩阵
  • 即时分子诊断市场：公司概况
    • Abbott Laboratories
    • F Hoffmann La Roche Ltd
    • BioMerieux SA
    • Hologic Inc
    • Becton Dickinson and Company

第37章：其他领先和创新企业

  • Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen NV, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年即时分子诊断市场：提供新机会的国家
  • 2030年即时分子诊断市场：蕴藏新机会的细分市场
  • 2030年即时分子诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MPOCM01_G26Q1

Point-of-care (POC) molecular diagnostics are tests designed to detect specific nucleic acids in clinical specimens, including feces, saliva, urine, blood, and tissue. These diagnostics rely on identifying targeted portions of microbial genetic material, specifically DNA or RNA. Widely utilized in the healthcare sector, POC molecular diagnostics are granted emergency usage authorization to diagnose various diseases. These diagnostics are instrumental in detecting disease antigens or antibodies in human samples, such as mononucleosis, influenza, and group A streptococcus (GAS).

The primary products and services in point-of-care molecular diagnostics include assays and kits, instruments and analyzers, and software and services. Assays and kits are equipment used to carry out analyses, especially in studying disease pathways. They are commonly employed for rapid and accurate diagnosis and monitoring of various diseases. Technologies such as reverse transcription-polymerase chain reaction (RT-PCR), in situ hybridization, and sequencing are utilized in POC molecular diagnostics for diagnosing diseases like respiratory diseases, hospital-acquired infections (HAIs), cancer/oncology, hepatitis, and hematology. Point-of-care molecular diagnostics are employed in decentralized labs, hospitals, home care, and assisted living healthcare facilities.

Tariffs are impacting the point-of-care molecular diagnostics market by increasing costs of imported reagents, microfluidic cartridges, analyzers, sensors, and semiconductor components. Healthcare systems in North America and Europe are most affected due to dependence on imported diagnostic hardware, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are raising test prices and influencing procurement decisions. However, they are also driving domestic manufacturing, regional reagent production, and localized development of cost-efficient POC molecular diagnostic platforms.

The point-of-care molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides point-of-care molecular diagnostics market statistics, including point-of-care molecular diagnostics industry global market size, regional shares, competitors with a point-of-care molecular diagnostics market share, detailed point-of-care molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care molecular diagnostics industry. This point-of-care molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care molecular diagnostics market size has grown rapidly in recent years. It will grow from $3.98 billion in 2025 to $4.58 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, expansion of emergency diagnostic testing, rising demand for rapid clinical decision support, improvements in molecular assay technologies, growing use of poc diagnostics in hospitals.

The point-of-care molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $7.91 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to increasing adoption of home-based molecular testing, rising investments in rapid diagnostics infrastructure, expansion of respiratory and oncology testing applications, growing integration of cloud-based diagnostic platforms, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of rapid molecular testing platforms, rising demand for decentralized diagnostic solutions, growing integration of automated sample processing, expansion of syndromic testing panels, enhanced focus on fast turnaround times.

The rapid increase in the prevalence of infectious and respiratory diseases is anticipated to play a significant role in supporting the growth of the point-of-care molecular diagnostics market. Respiratory infections, caused by viral or bacterial pathogens, affect the respiratory system and are commonly transmitted through coughing, sneezing, or direct physical contact. The management of these conditions involves a wide range of therapeutic approaches, including inhalers, oral drugs, intravenous therapies, and point-of-care molecular diagnostic solutions that support timely and accurate treatment. For example, in June 2024, according to the UK Health Security Agency, between week 40 of 2022 and week 15 of 2023, a total of 108 National Health Service trusts in England reported 1,681 critical care admissions linked to confirmed influenza cases. This represented a sharp rise compared with the previous season, which recorded 182 admissions across 114 trusts, increasing to 316 by week 39 of 2022. Therefore, the growing incidence of infectious and respiratory diseases, along with associated mortality risks, is driving demand for point-of-care molecular diagnostic solutions.

Major companies operating in the point-of-care molecular diagnostics market are concentrating on delivering technologically advanced solutions to reinforce their competitive positioning. These players are adopting next-generation point-of-care molecular diagnostic technologies and associated services, including enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), in situ hybridization, spectral karyotyping imaging, DNA microarrays, and related techniques, for integration into point-of-care devices with the objective of reducing analysis time and lowering overall costs. For example, in May 2023, Sensible Diagnostics, a United States-based diagnostics company, introduced a 10-minute point-of-care PCR system. The company is leveraging the expertise gained by Curative through its diagnostics operations during the COVID-19 pandemic. Sensible Diagnostics reported that it has conducted more than two million molecular point-of-care COVID-19 tests, and its PCR platform delivers results within a 10-minute timeframe.

In July 2024, Roche Holding AG, a Switzerland-based global healthcare company focused on developing medicines, treatments, and diagnostics, acquired LumiraDx Ltd. for an undisclosed amount. This acquisition is intended to enhance Roche Holding AG's diagnostics portfolio, improve access to decentralized healthcare solutions, and expand testing capabilities, especially in underserved regions. LumiraDx Ltd. is a UK-based diagnostic company that specializes in creating innovative point-of-care (POC) testing solutions.

Major companies operating in the point-of-care molecular diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, BioMerieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc

North America was the largest region in the point-of-care molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The point-of-care (POC) molecular diagnostics market includes revenues earned by AAT, antigen, or antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-Of-Care Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses point-of-care molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Assays And Kits; Instruments And Analyzers
  • 2) By Application: Respiratory Infections; Gastrointestinal Infections; Sexually Transmitted Infections (STIs); Hospital-Acquired Infections (HAIs); Bloodstream and Sepsis-Related Infections
  • 3) By End-User: Decentralized Labs; Hospitals; Home Care; Assisted Living Healthcare Facilities
  • Subsegments:
  • 1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs); Rapid Diagnostic Tests; Molecular Detection Kits; Reagents And Consumables
  • 2) By Instruments And Analyzers: Microfluidic Devices; Point-of-Care Analyzers
  • Companies Mentioned: Abbott Laboratories; F Hoffmann La Roche Ltd; BioMerieux SA; Hologic Inc; Becton Dickinson and Company; Siemens Healthineers AG; QuidelOrtho Corporation; Bio Rad Laboratories Inc; Qiagen N V; Biocartis Group NV; DiaSorin S p A; SD Biosensor Inc; Cue Health Inc; Visby Medical Inc; Binx Health Inc; Molbio Diagnostics Pvt Ltd; Credo Diagnostics Biomedical Pvt Ltd; Genetron Health; Mammoth Biosciences Inc; Seegene Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Point-Of-Care Molecular Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Point-Of-Care Molecular Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Point-Of-Care Molecular Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Point-Of-Care Molecular Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Rapid Molecular Testing Platforms
    • 4.2.2 Rising Demand For Decentralized Diagnostic Solutions
    • 4.2.3 Growing Integration Of Automated Sample Processing
    • 4.2.4 Expansion Of Syndromic Testing Panels
    • 4.2.5 Enhanced Focus On Fast Turnaround Times

5. Point-Of-Care Molecular Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Decentralized Laboratories
  • 5.3 Home Care Providers
  • 5.4 Assisted Living Healthcare Facilities
  • 5.5 Diagnostic Clinics

6. Point-Of-Care Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point-Of-Care Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Point-Of-Care Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Point-Of-Care Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Point-Of-Care Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Point-Of-Care Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point-Of-Care Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point-Of-Care Molecular Diagnostics Market Segmentation

  • 9.1. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Assays And Kits, Instruments And Analyzers
  • 9.2. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections
  • 9.3. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities
  • 9.4. Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Assays And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables
  • 9.5. Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Instruments And Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microfluidic Devices, Point-of-Care Analyzers

10. Point-Of-Care Molecular Diagnostics Market Regional And Country Analysis

  • 10.1. Global Point-Of-Care Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Point-Of-Care Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point-Of-Care Molecular Diagnostics Market

  • 11.1. Asia-Pacific Point-Of-Care Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point-Of-Care Molecular Diagnostics Market

  • 12.1. China Point-Of-Care Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point-Of-Care Molecular Diagnostics Market

  • 13.1. India Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point-Of-Care Molecular Diagnostics Market

  • 14.1. Japan Point-Of-Care Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point-Of-Care Molecular Diagnostics Market

  • 15.1. Australia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point-Of-Care Molecular Diagnostics Market

  • 16.1. Indonesia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point-Of-Care Molecular Diagnostics Market

  • 17.1. South Korea Point-Of-Care Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point-Of-Care Molecular Diagnostics Market

  • 18.1. Taiwan Point-Of-Care Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point-Of-Care Molecular Diagnostics Market

  • 19.1. South East Asia Point-Of-Care Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point-Of-Care Molecular Diagnostics Market

  • 20.1. Western Europe Point-Of-Care Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point-Of-Care Molecular Diagnostics Market

  • 21.1. UK Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point-Of-Care Molecular Diagnostics Market

  • 22.1. Germany Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point-Of-Care Molecular Diagnostics Market

  • 23.1. France Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point-Of-Care Molecular Diagnostics Market

  • 24.1. Italy Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point-Of-Care Molecular Diagnostics Market

  • 25.1. Spain Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point-Of-Care Molecular Diagnostics Market

  • 26.1. Eastern Europe Point-Of-Care Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point-Of-Care Molecular Diagnostics Market

  • 27.1. Russia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point-Of-Care Molecular Diagnostics Market

  • 28.1. North America Point-Of-Care Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point-Of-Care Molecular Diagnostics Market

  • 29.1. USA Point-Of-Care Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point-Of-Care Molecular Diagnostics Market

  • 30.1. Canada Point-Of-Care Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point-Of-Care Molecular Diagnostics Market

  • 31.1. South America Point-Of-Care Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point-Of-Care Molecular Diagnostics Market

  • 32.1. Brazil Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point-Of-Care Molecular Diagnostics Market

  • 33.1. Middle East Point-Of-Care Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point-Of-Care Molecular Diagnostics Market

  • 34.1. Africa Point-Of-Care Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point-Of-Care Molecular Diagnostics Market Regulatory and Investment Landscape

36. Point-Of-Care Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Point-Of-Care Molecular Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Point-Of-Care Molecular Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Point-Of-Care Molecular Diagnostics Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F Hoffmann La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Hologic Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Point-Of-Care Molecular Diagnostics Market Other Major And Innovative Companies

  • Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc

38. Global Point-Of-Care Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point-Of-Care Molecular Diagnostics Market

40. Point-Of-Care Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Point-Of-Care Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Point-Of-Care Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Point-Of-Care Molecular Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer